[144] UNITED THERAPEUTICS Corp SEC Filing

Rhea-AI Filing Summary

UNITED THERAPEUTICS (UTHR) Form 144 summary: A holder intends to sell 1,800 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ with an approximate aggregate market value of $747,767.70. The shares were acquired on 07/13/2024 as restricted stock from the issuer and were fully paid on that date. The filing lists an approximate total outstanding share count of 45,226,262 and an approximate sale date of 09/19/2025. No securities were reported sold by the same person in the past three months. The filer certifies they are unaware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR Proposed sale is a limited number of restricted shares executed through a broker; impact appears routine.

The filing documents a planned disposition of 1,800 restricted common shares with an aggregate market value of $747,767.70, to be executed via Morgan Stanley Smith Barney on NASDAQ around 09/19/2025. The shares were originally granted by the issuer on 07/13/2024 and fully paid the same day. No other sales by this person are reported in the prior three months. From a trading-flow perspective, this is a single-holder notice required by Rule 144 and, by itself, does not provide information about company performance.

Corporate Governance Expert

TL;DR This is a compliance filing documenting a planned sale of restricted stock; governance implications are procedural.

The notice confirms the securities were acquired as restricted stock from the issuer and that the seller represents no undisclosed material adverse information exists. The use of a broker and the absence of other recent sales suggest the filer is following Rule 144 procedures for public disposition. The filing does not disclose any changes in officer/director status, control transfers, or additional governance actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1800	747767.70	45226262	09/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/13/2024	Restricted Stock	Issuer			1800	07/13/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the UTHR Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 1,800 common shares via Morgan Stanley Smith Barney with an aggregate market value of $747,767.70, to be sold on 09/19/2025 on the NASDAQ.

When and how were the securities acquired according to the filing?

The securities were acquired on 07/13/2024 as restricted stock from the issuer and payment was completed on that date.

Does the filer report any securities sold in the past three months for UTHR?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are named in the Form 144 for UTHR?

The broker is Morgan Stanley Smith Barney LLC and the named exchange for the proposed sale is the NASDAQ.

What certification does the seller provide in the remarks section?

The seller represents by signing the notice that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.